Penn Muluhngwi
Penn Muluhngwi
University of Louiville
Verified email at louisville.edu
Title
Cited by
Cited by
Year
Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells
TT Manavalan, Y Teng, LM Litchfield, P Muluhngwi, N Al-Rayyan, ...
PloS one 8 (4), e62334, 2013
922013
Roles for miRNAs in endocrine resistance in breast cancer
P Muluhngwi, CM Klinge
Endocrine-related cancer 22 (5), R279, 2015
552015
Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer
P Muluhngwi, CM Klinge
Molecular and cellular endocrinology 456, 76-86, 2017
262017
Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells
BN Radde, MM Ivanova, HX Mai, N Alizadeh-Rad, K Piell, P Van Hoose, ...
Experimental cell research 347 (1), 222-231, 2016
242016
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells
P Muluhngwi, A Krishna, SL Vittitow, JT Napier, KM Richardson, M Ellis, ...
Cancer letters 388, 230-238, 2017
232017
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
P Muluhngwi, N Alizadeh-Rad, SL Vittitow, TS Kalbfleisch, CM Klinge
Scientific reports 7 (1), 1-10, 2017
182017
Transcriptomic response of breast cancer cells to anacardic acid
DJ Schultz, A Krishna, SL Vittitow, N Alizadeh-Rad, P Muluhngwi, ...
Scientific reports 8 (1), 1-16, 2018
92018
Genome-wide miRNA response to anacardic acid in breast cancer cells
DJ Schultz, P Muluhngwi, N Alizadeh-Rad, MA Green, EC Rouchka, ...
Plos one 12 (9), e0184471, 2017
72017
Cell-free DNA diagnostics: Current and emerging applications in oncology
P Muluhngwi, R Valdes Jr, R Fernandez-Botran, E Burton, B Williams, ...
Pharmacogenomics 20 (05), 357-380, 2019
32019
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells
P Muluhngwi, K Richardson, J Napier, EC Rouchka, JL Mott, CM Klinge
Molecular and cellular endocrinology 444, 38-47, 2017
32017
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
P Muluhngwi, CN Sharp, N Pozzi, RJ Elin, SA Jortani
Journal of Applied Laboratory Medicine 4 (3), 323-330, 2019
2019
Circulating Antibodies to R132H Isocitrate Dehydrogenase as a “Liquid Biopsy” Biomarker of Gliomas.:[47]
P Muluhngwi, R Valdes, M Linder
Annals of Clinical & Laboratory Science 48 (3), 410-411, 2018
2018
Tamoxifen differentially regulates miR-29b-1 and miR-29a depending on endocrine sensitivity in breast cancer
P Muluhngwi, CM Klinge
Cancer Research 77 (13 Supplement), 3428-3428, 2017
2017
Transcriptomic Profiling of Anacardic Acid-Treated Breast Cancer Cells
CM Klinge, N Alizadeh-Rad, P Muluhngwi, EC Rouchka, DJ Schultz
99th Annual Meeting of the Endocrine Society, 2017
2017
Role of Mir-29b-1/a in Acquired Endocrine-Resistant Breast Cancer
A Krishna, S Vittitow, P Muluhngwi, CM Klinge
99th Annual Meeting of the Endocrine Society, 2017
2017
Role of MIR-29B-1 and MIR-29A in endocrine-resistant breast cancer.
P Muluhngwi
2017
Role of Increased Mir-29b-1 and Mir-29a in Endocrine-Resistant Breast Cancer
P Muluhngwi, JT Napier, CM Klinge
Metastasis and Tumor Progression, Neoplasia of Endocrine Tissue, Therapies …, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–17